Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L Mega

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Circulation|May 6, 2009
Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal. Acute Cardiovascular Care|October 17, 2014
The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trialMatthew A Cavender, C Michael Gibson, Eugene Braunwald, et al.
Journal of the American College of Cardiology|April 16, 2013
Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding eventsJosep Rodés-Cabau, Harold L Dauerman, Mauricio G Cohen, et al.
Cardiovascular Diabetology|July 19, 2022
Multi-dimensional characterization of prediabetes in the Project Baseline Health StudyRanee Chatterjee, Lydia Coulter Kwee, Neha Pagidipati, et al.
JAMA|November 30, 2016
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus PhotographsVarun Gulshan, Lily Peng, Marc Coram, et al.
Lancet (London, England)|March 15, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trialJessica L Mega, Joseph R Walker, Christian T Ruff, et al.
Journal of Cardiac Failure|April 28, 2023
Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure StagingNicholas Cauwenberghs, Francois Haddad, Melissa A Daubert, et al.
Journal of the American College of Cardiology|July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trialWillibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
American Heart Journal|September 3, 2011
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapyWillibald Hochholzer, Dietmar Trenk, Jessica L Mega, et al.
Lancet (London, England)|September 4, 2009
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trialsMichelle L O'Donoghue, Eugene Braunwald, Elliott M Antman, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Circulation|May 6, 2009
Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal. Acute Cardiovascular Care|October 17, 2014
The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trialMatthew A Cavender, C Michael Gibson, Eugene Braunwald, et al.
Journal of the American College of Cardiology|April 16, 2013
Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding eventsJosep Rodés-Cabau, Harold L Dauerman, Mauricio G Cohen, et al.
Cardiovascular Diabetology|July 19, 2022
Multi-dimensional characterization of prediabetes in the Project Baseline Health StudyRanee Chatterjee, Lydia Coulter Kwee, Neha Pagidipati, et al.
JAMA|November 30, 2016
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus PhotographsVarun Gulshan, Lily Peng, Marc Coram, et al.
Lancet (London, England)|March 15, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trialJessica L Mega, Joseph R Walker, Christian T Ruff, et al.
Journal of Cardiac Failure|April 28, 2023
Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure StagingNicholas Cauwenberghs, Francois Haddad, Melissa A Daubert, et al.
Journal of the American College of Cardiology|July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trialWillibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
American Heart Journal|September 3, 2011
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapyWillibald Hochholzer, Dietmar Trenk, Jessica L Mega, et al.
Lancet (London, England)|September 4, 2009
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trialsMichelle L O'Donoghue, Eugene Braunwald, Elliott M Antman, et al.
Pageof 7